Literature DB >> 18021253

Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma.

Dorina Veliceasa1, Marina Ivanovic, Frank Thilo-Schulze Hoepfner, Praveen Thumbikat, Olga V Volpert, Norm D Smith.   

Abstract

Angiogenic switch in renal cell carcinoma (RCC) is attributed to the inactivation of the von Hippel-Lindau tumor suppressor, stabilization of hypoxia inducible factor-1 transcription factor and increased vascular endothelial growth factor. To evaluate the role of an angiogenesis inhibitor, thrombopsondin-1 (TSP1), we compared TSP1 production in human RCC and normal tissue and secretion by the normal renal epithelium (human normal kidney, HNK) and RCC cells. Normal and RCC tissues stained positive for TSP1, and the levels of TSP1 mRNA and total protein were similar in RCC and HNK cells. However, HNK cells secreted high TSP1, which rendered them nonangiogenic, whereas RCC cells secreted little TSP1 and were angiogenic. Western blot and immunostaining revealed TSP1 in the cytoplasm of RCC cells on serum withdrawal, whereas, in HNK cells, it was rapidly exported. Seeking mechanisms of defective TSP1 secretion, we discovered impaired calcium uptake by RCC in response to vascular endothelial growth factor. In HNK cells, 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester, a calcium chelator, simulated TSP1 retention, mimicking the RCC phenotype. Further analysis revealed a profound decrease in transient receptor potential canonical ion channel 4 (TRPC4) Ca(2+) channel expression in RCC cells. TRPC4 silencing in HNK cells caused TSP1 retention and impaired secretion. Double labeling of the secretory system components revealed TSP1 colocalization with coatomer protein II (COPII) anterograde vesicles in HNK cells. In contrast, in RCC cells, TSP1 colocalized with COPI vesicles, pointing to the retrograde transport to the endoplasmic reticulum caused by misfolding. Our study indicates that TRPC4 loss in RCC leads to impaired Ca(2+) intake, misfolding, retrograde transport and diminished secretion of antiangiogenic TSP1, thus enabling angiogenic switch during RCC progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021253     DOI: 10.1111/j.1742-4658.2007.06159.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  35 in total

Review 1.  Crosstalk between calcium and reactive oxygen species signaling in cancer.

Authors:  Nadine Hempel; Mohamed Trebak
Journal:  Cell Calcium       Date:  2017-01-18       Impact factor: 6.817

Review 2.  Transient receptor potential canonical channels in angiogenesis and axon guidance.

Authors:  Peng-Chun Yu; Jiu-Lin Du
Journal:  Cell Mol Life Sci       Date:  2011-07-14       Impact factor: 9.261

3.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

4.  Thrombospondin 1 protects pancreatic β-cells from lipotoxicity via the PERK-NRF2 pathway.

Authors:  Daniel A Cunha; Monia Cito; Per-Ola Carlsson; Jean-Marie Vanderwinden; Jeffery D Molkentin; Marco Bugliani; Piero Marchetti; Décio L Eizirik; Miriam Cnop
Journal:  Cell Death Differ       Date:  2016-09-02       Impact factor: 15.828

5.  Cdk9 T-loop phosphorylation is regulated by the calcium signaling pathway.

Authors:  Rajesh Ramakrishnan; Andrew P Rice
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

6.  The TRPC5 channel regulates angiogenesis and promotes recovery from ischemic injury in mice.

Authors:  Yifei Zhu; Mengru Gao; Tingting Zhou; Mingxu Xie; Aiqin Mao; Lei Feng; Xiaoqiang Yao; Wing Tak Wong; Xin Ma
Journal:  J Biol Chem       Date:  2018-11-09       Impact factor: 5.157

7.  Pancreatic β-cell protection from inflammatory stress by the endoplasmic reticulum proteins thrombospondin 1 and mesencephalic astrocyte-derived neutrotrophic factor (MANF).

Authors:  Daniel A Cunha; Monia Cito; Fabio Arturo Grieco; Cristina Cosentino; Tatiana Danilova; Laurence Ladrière; Maria Lindahl; Andrii Domanskyi; Marco Bugliani; Piero Marchetti; Décio L Eizirik; Miriam Cnop
Journal:  J Biol Chem       Date:  2017-07-11       Impact factor: 5.157

Review 8.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

Review 9.  Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.

Authors:  Y Mirochnik; A Kwiatek; O V Volpert
Journal:  Curr Drug Targets       Date:  2008-10       Impact factor: 3.465

10.  ATF6 [corrected] and thrombospondin 4: the dynamic duo of the adaptive endoplasmic reticulum stress response.

Authors:  Shirin Doroudgar; Christopher C Glembotski
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.